What Gene Mutation Causes Cystic Fibrosis?

Chromosome 7q31 carries more than 2,000 documented variants of the CFTR gene, and roughly 400 of them are known to cause cystic fibrosis.2 causes cystic fibrosis, and a single three-nucleotide deletion called DeltaF508 accounts for roughly 66 to 70 percent of CF chromosomes worldwide. That defect disrupts a chloride channel your cells need to keep airway and duct surfaces hydrated, which is why thick mucus, chronic lung infections, and pancreatic damage follow.

Knowing exactly which mutation is involved explains inheritance risk, symptom severity, and which targeted therapies may fit your situation.

Below, we’ll walk through the CFTR mutation on chromosome 7q31.2, explain how the DeltaF508 deletion breaks chloride flow, and break down the six mutation classes that guide today’s targeted therapies.

Cystic Fibrosis Is a Single-Gene Disease With a Known Cause

Cystic fibrosis affects roughly 30,000 people in the United States and about 70,000 worldwide, making it one of the most common inherited disorders in people of Northern European descent. Unlike conditions shaped by diet, environment, or dozens of genes, CF traces directly to defects in one specific gene called CFTR, located on the long arm of chromosome 7 at position 7q31.2.

CFTR stands for Cystic Fibrosis Transmembrane Conductance Regulator, a name that signals its job rather plainly. The gene encodes a chloride channel embedded in the surface of many cells, controlling how salt and water move across epithelial tissues. When CFTR works correctly, it shuttles chloride and indirectly bicarbonate out of cells, keeping airway surfaces, pancreatic ducts, intestines, and reproductive tissues thin and free-flowing.

The chloride channel is shaped like a tiny gate set into the cell membrane. Open the gate and chloride ions flow out, drawing water with them to hydrate the surface layer. Close it and the layer dehydrates, turning protective mucus into something closer to wallpaper paste. Every downstream problem in CF, from persistent coughs to poor weight gain, traces back to that single gate failing to open on schedule.

Knowing the gene sets the stage, but most patients share the exact same typo and that concentration shapes every research and treatment strategy.

Delta F508 Is the Mutation Behind Most Cystic Fibrosis Cases

The single most common CF-causing mutation is written as DeltaF508 or F508del, a deletion of three nucleotides that removes one phenylalanine amino acid from position 508 of the CFTR protein. That missing building block distorts the protein’s shape just enough to cause everything downstream to fail.

Around 66 to 70 percent of all CF chromosomes worldwide carry DeltaF508, and roughly half of people with cystic fibrosis inherit two copies of the mutation, one from each parent. Those individuals are called homozygous for DeltaF508, which matters because the severity and treatment options shift depending on which combination of mutations your child or you carry.

How Common Is DeltaF508 Across Ethnic Groups?

DeltaF508 is not evenly distributed across populations. It accounts for about 70 to 75 percent of CF chromosomes in Caucasian populations of European ancestry, but far less in Hispanic, African, and Asian groups, where other CFTR variants make up a larger share. That distribution helps explain why newborn screening panels sometimes look different in different regions.

The mutation was identified in 1989 when Lap-Chee Tsui, Jack Riordan, and Francis Collins used positional cloning to pinpoint CFTR, a landmark that turned CF into the first major disease decoded by the human genome project. Within a few years, genetic testing for carriers became possible, and the door opened for mutation-specific drug design that is still expanding today.

Population GroupApprox. Share of CF Chromosomes Carrying DeltaF508
Caucasian (European ancestry)70 to 75 percent
HispanicAbout 50 to 60 percent
AfricanAround 30 to 40 percent
AsianOften under 30 percent

How a Three-Letter Deletion Breaks the Chloride Channel

Removing three nucleotides from the CFTR gene might sound small, but it sets off a chain reaction that disables the entire chloride channel. The 1,480-amino-acid protein loses one phenylalanine at position 508, and that single gap corrupts the protein’s three-dimensional fold.

The Four Steps From Deletion to Thick Mucus

  1. Step 1: The deletion. DeltaF508 removes the genetic instructions for one phenylalanine, distorting the folding map of the entire CFTR protein.
  2. Step 2: Misfolding and ER retention. The cell’s quality-control system in the endoplasmic reticulum recognizes the misshapen protein and tags it for destruction, so almost no functional CFTR reaches the cell surface.
  3. Step 3: Lost chloride transport. With no working channels, chloride and bicarbonate cannot exit epithelial cells, and sodium is over-absorbed in compensation.
  4. Step 4: Thick secretions. Water follows salt out of the surface layer, leaving airways, pancreatic ducts, intestines, and the vas deferens coated in dense, sticky mucus that drives infection, malabsorption, and male infertility.

Think of the protein as a four-leaf clover that has to fold into a precise shape before it can be installed in the cell membrane. The DeltaF508 mutation is like snipping one corner of the clover. The cell’s inspectors spot the damage and shred the part before it ever gets shipped, so the gate is missing in action by the time the surface needs it.

A broken gate explains the cellular mess, yet families still wonder how two unaffected parents can produce a child with the disease.

Inheritance Runs in an Autosomal Recessive Pattern From Both Parents

Cystic fibrosis is autosomal recessive, which means you must inherit two defective copies of CFTR, one from each parent, to develop the disease. Inheriting just one defective copy makes someone an asymptomatic carrier, and that distinction shapes family planning in a very practical way.

The Carrier Math Most People Miss

About 1 in 25 Caucasian Americans is a CF carrier, and roughly 1 in 2,500 to 3,500 babies in that population is born with CF, though the rate differs by ethnicity. When both parents are carriers, each child faces a fixed statistical pattern: a 25 percent chance of having CF, a 50 percent chance of being a carrier like the parents, and a 25 percent chance of inheriting neither defective copy.

Parent CombinationChance Child Has CFChance Child Is a CarrierChance Child Is Unaffected and Not a Carrier
Carrier + Carrier25 percent50 percent25 percent
Carrier + Affected50 percent50 percent0 percent
Affected + Affected100 percent0 percent0 percent

A negative family history does not rule out carrier status, because DeltaF508 and other CFTR mutations have been silently passed through generations for centuries before the gene was ever identified. Two healthy parents with no known relatives who have CF can still both be carriers and have a child with the disease.

Beyond Delta F508: The Class I to VI Mutation System

More than 2,000 CFTR variants have been catalogued, but only a subset reliably cause disease, and they fall into six functional classes based on what goes wrong in the protein’s life cycle. The class system matters because it predicts which drugs are likely to help and how severe the symptoms may be.

  • Class I mutations: G542X and W1282X introduce premature stop signals that leave no full-length CFTR protein at all.
  • Class II mutations: DeltaF508 belongs here, causing misfolding and ER degradation so the protein is made but never reaches the cell membrane.
  • Class III mutations: G551D reaches the surface but fails to open and conduct chloride properly.
  • Class IV mutations: These channels open poorly and conduct less chloride per opening.
  • Class V mutations: Reduce the amount of correctly processed protein reaching the surface.
  • Class VI mutations: Destabilize CFTR once it is installed in the membrane, shortening its working life.

Two people with the same disease label can therefore have very different symptoms and drug responses, because their underlying mutation class shapes how the chloride channel fails. That detail explains why genetic testing is recommended as soon as CF is suspected, even before sweat chloride results come back.

Once the mutation classes are mapped, clinicians can translate that detail into earlier screening, targeted therapies, and family planning conversations.

Turning This Genetic Knowledge Into Action

Knowing the exact CFTR mutation is now the first step toward choosing the right therapy, qualifying for clinical trials, and understanding what to expect as treatment continues to evolve. The days of treating CF as a single uniform condition are ending, and the mutation panel is the new front door.

Carrier Screening and Genetic Counseling

Carrier screening is widely available through a simple blood or saliva panel that looks for the 23 to 100 most common CFTR mutations, including DeltaF508, and is routinely offered to couples planning a pregnancy. A genetic counselor can translate the results into clear probabilities, discuss prenatal testing options, and walk you through preimplantation genetic testing during IVF for couples who want to reduce the chance of passing on two defective copies.

Mutation-Specific Therapies

Three classes of CFTR modulators, potentiators, correctors, and amplifiers, have reshaped treatment by addressing distinct defect categories at the protein level. Ivacaftor, for example, rescues gating defects in Class III mutations like G551D by holding the channel open longer. The triple combination elexacaftor-tezacaftor-ivacaftor, marketed as Trikafta, partially corrects the DeltaF508 misfolding and improves lung function for roughly 90 percent of people with CF who carry at least one copy of that mutation.

Ask your care team for a written copy of your full CFTR gene mutation panel. The exact two alleles shape both prognosis and which modulator therapies you may qualify for.

The CFTR gene discovery also opened the door to ongoing research into gene therapy approaches that aim to deliver a healthy copy of the gene directly to airway cells, a strategy still in clinical trials but watched closely by the CF community.

The Bottom Line

Cystic fibrosis traces to a single gene on chromosome 7, and one deletion, DeltaF508, drives most cases by misfolding a chloride channel before it ever reaches the cell surface. Knowing your or your child’s two specific CFTR alleles explains inheritance risk, predicts which modulator therapies may help, and connects you to a growing set of mutation-targeted treatments that were unimaginable before the gene was identified in 1989.

FAQ

What gene is responsible for cystic fibrosis?

Mutations in the CFTR gene on chromosome 7q31.2 cause cystic fibrosis. This gene encodes a chloride channel that keeps airway and digestive secretions thin, and defects in it drive every form of the disease you encounter.

Is cystic fibrosis caused by a mutation?

Inherited variants in the CFTR gene, passed from parents to child through autosomal recessive inheritance, are the sole cause of cystic fibrosis. You must inherit two defective copies, one from each parent, to develop the condition.

How is cystic fibrosis passed down genetically?

CF follows an autosomal recessive pattern, meaning both parents must pass on a defective CFTR copy for a child to be affected. Each child of two carrier parents has a 25 percent chance of having CF, a 50 percent chance of being a carrier, and a 25 percent chance of being completely unaffected.

What happens when the CFTR gene is mutated?

The CFTR protein misfolds, fails quality control inside the cell, or reaches the membrane but cannot open correctly. The result is poor chloride and bicarbonate transport, dehydrated surface layers, and thick mucus that clogs airways and ducts.

Can two carriers of the CFTR mutation have a child without cystic fibrosis?

Yes, two carriers have a 75 percent chance of having a child without CF in any single pregnancy, though the odds reset each time. The 25 percent affected, 50 percent carrier, 25 percent unaffected pattern applies independently to every pregnancy.

Are there different types of CFTR mutations?

Over 2,000 CFTR variants have been identified, and disease-causing ones are grouped into six functional classes based on how they break the protein. The most common is DeltaF508, a Class II folding defect responsible for roughly two-thirds of CF cases worldwide.

Staff
Staff

Our team brings together health and food enthusiasts who are passionate about discovering reliable health information, nutritious choices, and enjoyable food experiences. From everyday nutrition and healthy eating ideas to recipes, ingredients, food trends, and standout dishes, we share carefully researched and thoughtfully curated content to help readers make informed choices about what they eat and enjoy.